XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
6 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments

The following financial instruments were measured at fair value on a recurring basis:

 

Schedule of Fair Value of Financial Instruments

   December 31, 2022 
   Total   Level 1   Level 2   Level 3 
Contingent consideration (Note 12)  $6,192,912   $-   $-   $6,192,912 
Liability for the September 2022 Warrants (Note 11)  $2,267,454    -    -   $2,267,454 
Liability for the March 2022 Warrants (Note 11)  $172,500   $172,500   $-   $- 
Liability for the Series A and Series B Warrants (Note 11)  $16,777   $-   $-   $16,777 
Derivative liability on Senior Convertible Note (Note 2 and Note 11)  $799,954  $-   $-   $799,954
Schedule of Changes in Level 3 Financial Instruments

A summary of the changes in Level 3 financial instruments for the six months ended December 31, 2022 is as follows:

 

Schedule of Changes in Level 3 Financial Instruments

  

Warrant

Liability

  

Contingent

Consideration

  

Derivative liability

on Senior

Convertible Note

 
Balance at June 30, 2022  $122,730   $3,328,361   $9,399,620 
Fair value of the September 2022 Warrants (Note 11)   5,286,288    -    - 
Change in fair value of September 2022 Warrants (Note 11)   (1,482,103)   -    - 
Change in fair value of Series A and Series B Warrants issued with Senior Convertible Note (Note 11)   (105,953)   -    - 
Change in fair value of Bethard contingent consideration liability (Note 12)   -    (179,468)   - 
Change in the fair value of the derivative liability on Senior Convertible Note (Note 2 and Note 11)   -    -    (274,864)
Balance at September 30, 2022   3,820,962    3,148,893    9,124,756
Change in fair value of September 2022 Warrants (Note 11)   (1,536,732)   -    - 
Loss (gain) on Bethard contingent consideration liability (Note 12)   -    3,044,019    - 
Change in the fair value of the derivative liability on Senior Convertible Note (Note 2 and Note 11)   -    -    (8,324,802)
Balance at December 31, 2022  $2,284,230    6,192,912    799,954
Schedule of Warrants Outstanding Fair Value Assumption

The September 2022 Warrants were classified as Level 3 as they are plain vanilla warrants and are not callable by the Company (Note 11). The September 2022 Warrants were valued using a Black Scholes valuation model on issuance at September 19, 2022 and for the warrants outstanding at December 31, 2022 with the following assumptions:

 

Schedule of Warrants Outstanding Fair Value Assumption

   December 31, 2022   September 19, 2022 
Contractual term, in years   5.00    5.00 
Expected volatility   162%   167%
Risk-free interest rate   4.02%   3.69%
Dividend yield   -    - 
Conversion / exercise price  $0.25   $0.25 

 

The March 2022 Warrants were classified as Level 1 as they are publicly traded. They are callable by the Company if certain criteria are met (Note 11). The March 2022 Warrants outstanding at December 31, 2022 and June 30, 2022 were valued using the following assumptions:

 

   December 31, 2022   June 30, 2022 
Contractual term, in years   5.00    5.00 
Active market   Nasdaq    Nasdaq 
Market price  $0.01   $0.12 

 

The Series A and Series B Warrants outstanding at December 31, 2022 and June 30, 2022 are callable by the Company if certain criteria are met (Note 11) and were valued using a Monte Carlo valuation model with the following assumptions:

 

   December 31, 2022    June 30, 2022 
Contractual term, in years   2.004.00     2.004.00 
Expected volatility   135-190%    125% – 133%
Risk-free interest rate   3.96-4.24%    2.75% – 2.98%
Dividend yield   -     - 
Conversion / exercise price  $17.50    $17.50 

 

 

The value of the derivative liability on the Senior Convertible Note at December 31, 2022 and June 30, 2022 was valued using a nonperformance risk adjusted Monte Carlo valuation model using total assets less goodwill and an estimate of the Company’s total enterprise value with the following valuation assumptions:

 

   December 31, 2022   June 30, 2022 
Contractual term remaining, in years   0.42    0.92 
Expected volatility   162.78%   137.11%
De-leveraged volatility   32.81%   62.88%
Risk-free interest rate   4.55%   2.72 
Dividend yield        
Conversion / exercise price  $2.1832   $2.1832 
Schedule of Balance Sheet Derivative Instruments

The following is information relative to the Company’s derivative instruments in the unaudited condensed consolidated balance sheets as of December 31, 2022 and June 30, 2022:

 

 

Derivatives Not Designated as

Hedging Instruments

 

Balance

Sheet Location

  December 31, 2022   June 30, 2022 
Derivative liability on Senior Convertible Note (Note 2 and 11)  Derivative liability  $799,954  $9,399,620 

 

Schedule of Statement of Operation Derivative Instruments

The effect of the derivative instruments on the unaudited condensed consolidated statements of operations is as follows:

 

 

Derivatives Not  Location of Gain or (Loss)  Amount of Gain (Loss) Recognized in Income on Derivatives 

Designated as

Hedging

 

Recognized in

Income on

 

Three months ended

December 31,

  

Six months ended

December 31,

 
Instruments  Derivatives  2022   2021   2022   2021 
Derivative liability on Senior Convertible Note (Note 2 and 11)  Change in fair value of derivative liability on Senior Convertible Note  $8,324,802  $(1,482,621)  $8,599,666  $(1,482,621)